Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May-Jun;18(3):173-7.
doi: 10.1016/j.jstrokecerebrovasdis.2008.03.008.

Metabolic syndrome and its components as risk factors for first-ever acute ischemic noncardioembolic stroke

Kenji Maruyama  1 , Shinichiro Uchiyama, Makoto Iwata
Affiliations

Metabolic syndrome and its components as risk factors for first-ever acute ischemic noncardioembolic stroke

Kenji Maruyama et al. J Stroke Cerebrovasc Dis. 2009 May-Jun.

Abstract

Background: Metabolic syndrome (MetS) has been studied as a cardiovascular risk factor. We evaluated MetS and its individual components as risk factors for acute ischemic noncardioembolic stroke (AINS).

Methods: The relationships of AINS with MetS and its components were analyzed in 200 patients with first-ever AINS and 200 age-matched control subjects.

Results: Patients with AINS had a higher MetS prevalence than control subjects (45.5% v 26.5%, P < .001). On logistic regression analysis, the adjusted odds ratio (OR) for MetS as a risk factor for AINS was 2.39 (95% confidence interval [CI] 1.14-4.98, P = .021). The AINS risk increased as the number of MetS components increased. Hypertension (OR 3.21, 95% CI 1.48-6.94, P = .003) and fasting hyperglycemia (OR 2.73, 95% CI 1.53-4.87, P = .001) were particularly significant risk factors among MetS components for AINS.

Conclusion: MetS is an independent risk factor for AINS. Stroke risk increased as the number of MetS components increased. Hypertension and hyperglycemia were particularly significant components as risk factors for AINS.

PubMed Disclaimer